Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study

BACKGROUND: Pneumocystis pneumonia (PCP) is a potentially life-threatening infection. Trimethoprim-sulfamethoxazole (TMP-SMX) is considered as the first regimen for PCP prophylaxis according to several guidelines. The recommended prophylactic dose of TMP-SMX has been determined based on patients wit...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Infect Dis
Autori principali: Yamashita, Kanae, Shimomura, Yoshimitsu, Ikesue, Hiroaki, Muroi, Nobuyuki, Yoshimoto, Akihiro, Hashida, Tohru
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8268304/
https://ncbi.nlm.nih.gov/pubmed/34238239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-021-06374-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi